Kelsey Lewis, MD
Family Medicine · Tucson, AZNPI 1689012189
Payments from drug & device makers
Across 248 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$534
- Novo Nordisk$461
- Pfizer$327
- Abbott$305
- Amgen$269
- GSK$255
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,00297%
- Other$1203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $534 |
| Novo Nordisk | 35 | $461 |
| Pfizer | 27 | $327 |
| Abbott | 12 | $305 |
| Amgen | 16 | $269 |
| GSK | 14 | $255 |
| Johnson & Johnson | 18 | $249 |
| AstraZeneca | 12 | $245 |
| Boehringer Ingelheim | 8 | $154 |
| Novartis | 8 | $150 |
| Sanofi-aventis U.S. LLC | 9 | $147 |
| Aimmune Therapeutics, Inc. | 6 | $91 |
| Lilly USA, LLC | 5 | $87 |
| Sanofi Pasteur Inc. | 4 | $71 |
| Merck | 5 | $69 |
| Nestle Healthcare Nutrition Inc. | 5 | $67 |
| Astellas Pharma US Inc | 3 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Exact Sciences | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Protega Pharmaceutials Inc | 1 | $35 |
| Corcept Therapeutics | 1 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Boston Scientific | 1 | $22 |
| Eisai Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| GE HealthCare | 1 | $17 |
| Globus Medical | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Gilead | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Bayer | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$4,122 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $71,938 |
| JardianceEmpagliflozin | 37 | $58,308 |
| JanuviaSitagliptin Phosphate | 43 | $38,847 |
| OzempicSemaglutide | 20 | $31,435 |
| MounjaroTirzepatide | 22 | $28,026 |
| XareltoRivaroxaban | 25 | $25,193 |
| TrulicityDulaglutide | 16 | $20,165 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $18,819 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $18,812 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,656 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $10,845 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $8,238 |
| Repatha SureclickEvolocumab | 11 | $7,103 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $6,309 |
| Arnuity ElliptaFluticasone Furoate | 12 | $5,369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $327 | $73,36785 claims |
| Boehringer IngelheimJardiance | $154 | $58,30837 claims |
| Lilly USA, LLCMounjaro, Trulicity | $87 | $48,19238 claims |
| MerckJanuvia | $69 | $38,84743 claims |
| Novo NordiskOzempic | $461 | $31,43520 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta | $255 | $27,26448 claims |
| Johnson & JohnsonXarelto | $249 | $25,19325 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $245 | $25,12947 claims |
| AbbVieSynthroid | $534 | $1,61424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Tucson
- Dena PetersenTucson$14.7M
- John McGettiganTucson$8.3M
- Kevin PoundsTucson$1.9M
- Thili KulatilakeTucson$1.8M
- Judith BrownTucson$399K
- Hannah LeslieTucson$228K
- Charles MichieliTucson$111K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.